赛妥沙500毫克注射液

赛妥沙500毫克注射液 (Saituo Sha 500mg Injection) is a pharmaceutical product containing the active ingredient Rituximab. Rituximab is a monoclonal antibody designed to target and deplete B-cells, a type of white blood cell. It works by binding to the CD20 protein found on the surface of B-cells, marking them for destruction by the body’s immune system. This targeted action is crucial in treating certain conditions where B-cells play a significant role in disease progression.

Indications: Saituo Sha 500mg Injection is indicated for the treatment of various conditions, including certain types of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. Its use in these conditions aims to reduce the abnormal proliferation or activity of B-cells.

Dosage and Administration: The dosage and administration of Saituo Sha 500mg Injection are highly dependent on the specific condition being treated, the patient’s weight, and their response to therapy. It is administered intravenously by a qualified healthcare professional. Patients should strictly follow their doctor’s prescribed dosage and schedule.

Side Effects: Common side effects may include infusion-related reactions (fever, chills, rash), nausea, fatigue, and headache. More serious side effects can occur, such as infections, and reactivation of certain viruses. It is essential to report any unusual or severe symptoms to a healthcare provider immediately.

Storage: Saituo Sha 500mg Injection should be stored in its original packaging at a refrigerated temperature (2°C to 8°C). It should be protected from light and should not be frozen. Once prepared for infusion, it should be used within a specified timeframe as per healthcare professional guidelines.